SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001104659-20-129525
Filing Date
2020-11-25
Accepted
2020-11-25 16:28:27
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B4 tm2034164d9_424b4.htm 424B4 233663
2 GRAPHIC tm2034164d9_s1img001.jpg GRAPHIC 7685
3 GRAPHIC tm2034164d9_s1img003.jpg GRAPHIC 427141
4 GRAPHIC tm2034164d9_s1img002.jpg GRAPHIC 259899
  Complete submission text file 0001104659-20-129525.txt   1192045
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-249724 | Film No.: 201350963
SIC: 2834 Pharmaceutical Preparations